ATMI Opens U.S. Bioprocess Lab

ATMI, Inc. has opened a 100 square-meter, U.S.-based lab for applications development and testing at its Bloomington, MN manufacturing facility. The lab will support process operations using the ATMI’s LifeSciences portfolio of single-use bioprocess solutions, including bioprocess vessels, bioreactors, mixers and its fill/finish platform.
 
“The new location is a clear reflection of ATMI’s strategy to provide comprehensive bioprocess solutions and invest in customer support,” said senior vice president and general manager of ATMI LifeSciences, Mario Phillips. “The lab is fully equipped with ATMI technologies and equipment to perform cell culture, and it is staffed by experts in the field. The team at this site has extensive experience in cell culture bioprocesses development and scale-up, as well as more than 20 protein, virus and cell production processes that have been developed in ATMI’s proprietary bioreactors. The team will be fully focused on understanding the challenges that customers are faced with and applying their technical knowledge to offer guidance.”